Application of <sup>18</sup>F-fluorodeoxyglucose PET/CT in prediction of prognosis of advanced gastric cancer

SONG Jinling; WANG Xuejuan; YANG Zhi

您当前的位置：

首页 >

文章列表页 >

Application of ¹⁸F-fluorodeoxyglucose PET/CT in prediction of prognosis of advanced gastric cancer

更新时间：2026-06-18

- Application of ¹⁸F-fluorodeoxyglucose PET/CT in prediction of prognosis of advanced gastric cancer
- Vol. 27, Issue 2, Pages: 118-122(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Online First：16 May 2018，
  
  Published：16 May 2018
- 稿件说明：
移动端阅览
宋金龄,王雪鹃,杨志. ¹⁸F-脱氧葡萄糖PET/CT在进展期胃癌预后预测中的应用[J]. 肿瘤影像学, 2018, 27(2): 118-122
DOI：

宋金龄,王雪鹃,杨志. ¹⁸F-脱氧葡萄糖PET/CT在进展期胃癌预后预测中的应用[J]. 肿瘤影像学, 2018, 27(2): 118-122 DOI：

摘要

胃癌是中国致死率较高的恶性肿瘤之一。准确评估胃癌患者预后、行个体化治疗有利于延长患者生存期。

F-脱氧葡萄糖（

F-fluorodeoxyglucose，

F-FDG） PET/CT能同时提供代谢和形态学信息，在恶性肿瘤分期、疗效评估及预后预测等方面有独特优势。本文综述了治疗前及治疗早期

F-FDG PET/CT对进展期胃癌患者的预后预测价值。

Abstract

Gastric cancer is one of the malignant tumors with high mortality in China. Prediction of prognosis of the patients with advanced gastric cancer can benefit from accurate prognosis and individual treatment.

F-fluorodeoxyglucose (

F-FDG) PET/CT can provide both metabolic and morphological information

which becomes one of the most sensitive tools to stage

evaluate the efficacy of therapy and predict the outcomes of patients with malignancy. This paper reviews the predictive value of pretreatment and early

F-FDG PET/CT in prognosis for advanced gastric cancer.

关键词

Keywords

references

Views

1603

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Construction and preoperative noninvasive prediction of a cross-scale risk phenotype in pancreatic adenosquamous carcinoma using digital pathology and contrast-enhanced CT

Prediction of lymphovascular invasion using multiparametric MRI habitat radiomics based on machine learning algorithms in gastric cancer

Evaluation of prostate cancer across different treatment stages using 18F-FDG PET imaging

Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe

In vitro and in vivo evaluation of targeted probe 68 Ga-NOTA-376 constructed by non-site-specific labeling method for CLDN18.2

Related Author

BIAN Yun

CHEN Chengwei

JIAN Meicheng

SHAO Chengwei

YANG Xiaotang

SONG Ruirui

CUI Yanfen

MA Shaoqing

Related Institution

Department of Radiology, The First Affiliated Hospital of Naval Medical University

Shanxi Medical University Graduate School

Department of Imaging, Shanxi Province Cancer Hospital /Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University

Department of Information Management, Shanxi Province Cancer Hospital /Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University

Clinical Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences

AI问答

⁰

Application of 18F-fluorodeoxyglucose PET/CT in prediction of prognosis of advanced gastric cancer

DOI：

摘要

Abstract

关键词

Keywords

references

Application of ¹⁸F-fluorodeoxyglucose PET/CT in prediction of prognosis of advanced gastric cancer